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ABSTRACT  
   
The viscous lung mucus of cystic fibrosis (CF) patients is characterized by oxygen 
gradients, which creates a unique niche for bacterial growth. Pseudomonas aeruginosa and 
Staphylococcus aureus, two predominant microorganisms chronically infecting the 
airways of CF patients, typically localize in hypoxic regions of the mucus. While 
interspecies interactions between P. aeruginosa and S. aureus have been reported, little is 
known about the role of low oxygen in regulating these interactions. Studying interspecies 
interactions in CF lung disease is important as evidence suggests that microbial community 
composition governs disease progression. In this study, P. aeruginosa lab strain PAO1 and 
two primary clinical isolates from hypoxic tissues were cultured alone, or in combination, 
with methicillin resistant S. aureus (MRSA) strain N315 under hypoxic or normoxic 
conditions. Herein, it is shown for the first time that low oxygen conditions relevant to the 
CF lung affect the competitive behavior between P. aeruginosa and S. aureus. Specifically, 
S. aureus was able to better survive competition in hypoxic versus normoxic conditions. 
Competition data from different oxygen concentrations were consistent using PAO1 and 
clinical isolates even though differences in the level of competition were observed. PAO1 
strains carrying mutations in virulence factors known to contribute to S. aureus competition 
(pyocyanin/phzS, elastase/lasA and lasI quorum sensing/lasI) were used to determine 
which genes play a role in the differential growth inhibition.  The lasA and lasI mutants 
competed less effectively with S. aureus regardless of the oxygen level present in the 
culture compared to the isogenic wild type strain. These results are consistent with previous 
findings that elastase and lasI quorum sensing play a role in competitive behavior of P. 
aeruginosa and S. aureus. Interestingly, the phzS mutant competed less effectively in 
ii 
hypoxic conditions suggesting that pyocyanin may be important in microaerophilic 
conditions. This study demonstrates that oxygen plays a role in competition between P. 
aeruginosa and S. aureus and contributes to understanding CF environmental factors that 
may regulate microbial community dynamics important for disease progression with 
potential for development of therapeutic avenues. 
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A BRIEF BACKGROUND ON Pseudomonas aeruginosa 
The information presented in this background will be used in the chapter “Pseudomonas 
aeruginosa response to spaceflight and low shear modeled microgravity: Implications for 
astronaut health and the clinic”  to be published in Effect of Spaceflight and Analogue 
Culture on Human and Microbial Cells: Novel insights into Disease Mechanisms; 
Nickerson, C.A., Ott, C.M., Pellis, N., Eds.; Springer-Verlag.  
 
1.1 Occurrence and clinical importance 
Pseudomonas aeruginosa is a member of the Gamma Proteobacteria class of bacteria, 
belonging to the Pseudomonaceae family. Carle Gessard, a chemist and bacteriologist from 
Paris, discovered this microorganism in 1882 (Gessard, 1882). This facultative, motile, 
non-lactose fermenting Gram Negative rod is a highly adaptable bacterium that can 
colonize various environmental niches such as plants, animals, soil and marine 
environments (Khan, Ahsan, Taylor, & Kogure, 2010; Kimata, Nishino, Suzuki, & Kogure, 
2004; Stover et al., 2000). P. aeruginosa is an opportunistic pathogen that is responsible 
for 10-15% of the nosocomial infections worldwide (Blanc, Petignat, Janin, Bille, & 
Francioli, 1998), causing infections in the skin, eyes, urethra, ear and the respiratory tract 
of immunocompromised patients. In particular, P. aeruginosa causes severe infections in 
burn wound and cystic fibrosis (CF) patients. P. aeruginosa infections are difficult to treat 
because of their natural resistance and their ability to acquire resistance to several groups 
of antimicrobial agents. This microorganism has many of the known intrinsic and acquire 
antibiotic resistance mechanisms (Pechere & Kohler, 1999), which results in a multi-drug 
resistant phenotype (McGowan, 2006). 
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1.2 Virulence factors 
1.2.1 Quorum sensing 
P. aeruginosa regulates many virulence factors using interbacterial communication, called 
Quorum Sensing (QS). QS is a signaling mechanism that bacteria use to regulate gene 
expression in a population density-dependent matter. In this system, bacteria produce and 
secrete small signaling molecules called autoinducers; when these molecules reach a 
concentration threshold, they diffuse back into the cell and coordinate a response that will 
allow the bacteria to promote their survival as a group (Stevens, Schuster, & Rumbaugh, 
2012). P. aeruginosa uses QS to regulate the production of multiple virulence factors such 
as motility, biofilm formation, efflux pump expression, elastase, catalase, pyocyanin, 
rhamnolipid production, lectins, iron chelators, and exotoxin A (Williams & Camara, 2009) 
(Gambello, Kaye, & Iglewski, 1993; Hassett et al., 1999; Ochsner & Reiser, 1995; Toder, 
Ferrell, Nezezon, Rust, & Iglewski, 1994) (Brint & Ohman, 1995; Latifi et al., 1995; 
Pearson, Pesci, & Iglewski, 1997; Winzer et al., 2000). 
P. aeruginosa possesses three quorum-sensing systems: Las, Rhl and PQS with their 
corresponding autoinducers N-(3-oxo-dodecanoyl)-L-homoserine lactone (3-oxo-C12-
HSL), N-butanoyl-L-homoserine lactone (C4-HSL) and 2-heptyl-3-hydroxy-4-quinolone, 
respectively (Gambello & Iglewski, 1991; Passador, Cook, Gambello, Rust, & Iglewski, 
1993; Tashiro, Yawata, Toyofuku, Uchiyama, & Nomura, 2013). 
The Las system comprises the LasI synthase protein and the LasR transcriptional regulator. 
LasI produces the acyl homoserine lactone (AHL) autoinducer molecule 3-oxo-C12-HSL 
(Gambello & Iglewski, 1991; Pearson et al., 1994). In order for LasR to become an active 
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transcription factor, it binds to 3-oxo-C12-HSL, which allows this multimer complex to 
bind to DNA and regulate gene transcription (Kiratisin, Tucker, & Passador, 2002). The 
Rhl system consists of the RhlI synthase which produces the AHL C4-HSL and the 
transcriptional regulator RhlR, which upon binding its cognate autoinducer is activated to 
regulate gene expression (Ochsner, Koch, Fiechter, & Reiser, 1994; Pearson, Passador, 
Iglewski, & Greenberg, 1995). For the Pseudomonas quinolone signal (PQS) system, the 
PQS autoinducer signal is recognized by the cognate receptor PqsR and regulates the 
production of PQS along with other virulence factors such as pyocyanin, rhamnolipids and 
elastase (Gallagher, McKnight, Kuznetsova, Pesci, & Manoil, 2002).  
 
1.2.2 Biofilm formation and exopolysaccharides 
Biofilms are multicellular bacterial communities associated with a surface, and 
encapsulated in an extracellular polymeric matrix (EPS) made up of nucleic acids, proteins 
and polysaccharides that facilitate the interaction between cells and between cells and a 
surface (Flemming & Wingender, 2010). Biofilm formation can form on abiotic (non-
biological) and biotic surfaces (biological e.g. wounds, surgical implants, mucus in CF 
lung) (Donlan & Costerton, 2002), respectively and confers resistance against 
antimicrobial agents and immune mechanisms of defense, and disinfectants (Harmsen, 
Yang, Pamp, & Tolker-Nielsen, 2010). Briefly, biofilm occurs in a process that is initiated 
by surface attachment of planktonic bacteria forming a monolayer and multiplication; 
aggregation leading to microcolony formation and differentiation into structured, mature, 
antibiotic-resistant communities (Costerton, Stewart, & Greenberg, 1999; Lopez, 
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Vlamakis, & Kolter, 2010; O'Toole & Kolter, 1998; Stapper et al., 2004). In the CF lung 
mucus, P. aeruginosa forms a non-conventional type of biofilm, in which bacteria are self-
attached and are adhering to mucus compounds, and not the epithelial cell surface (Alhede 
et al., 2011; Lam, Chan, Lam, & Costerton, 1980). The following virulence factors are 
involved in P. aeruginosa biofilm formation: QS, type IV pili, flagella, free DNA, alginate, 
Pel and Psl polysaccharides and rhamnolipids (Boles, Thoendel, & Singh, 2005; Klausen 
et al., 2003; Singh et al., 2000; Stapper et al., 2004). The Psl-encoded exopolysaccharide 
is rich in mannose and galactose, and is involved in attachment, biofilm maintenance, and 
self-aggregation (Friedman & Kolter, 2004; Jackson, Starkey, Kremer, Parsek, & Wozniak, 
2004) (Jackson et al., 2004; Matsukawa & Greenberg, 2004) (Haussler et al., 2003; Ma, 
Jackson, Landry, Parsek, & Wozniak, 2006; Matsukawa & Greenberg, 2004; Sarkisova, 
Patrauchan, Berglund, Nivens, & Franklin, 2005; Smith et al., 2006). The Pel 
exopolysaccharide is rich in glucose, and is involved in the formation of pellicles in P. 
aeruginosa, i.e. microbial aggregations at the interface between air and liquid (Yamamoto, 
Arai, Ishii, & Igarashi, 2011, 2012; Yamamoto, Haruta, Kato, Ishii, & Igarashi, 2010).  
In the lungs of patients with CF, P. aeruginosa can convert from a non-mucoid to a mucoid 
phenotype through overproduction of the exopolysaccharide alginate, indicating a chronic 
infection (Pressler et al., 2011). Alginate is a polymer of -D-mannuronic acid and -L-
guluronic acid (Evans & Linker, 1973) that protects P. aeruginosa from phagocytosis and 
antibodies, giving the bacteria a survival advantage. Mucoidity conversion follows when 
biofilms are exposed to polymorphonuclear leucocytes (Mathee et al., 1999), antibiotics 
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(Govan & Fyfe, 1978), hydrogen peroxide (Mathee et al., 1999) and nutrient starvation 
(Speert et al., 1990; Terry, Pina, & Mattingly, 1991). 
The key player in the regulatory pathway leading to alginate production is the alternative 
sigma factor AlgU (also known as AlgT). AlgU is regulated by the algUmucABCD operon 
(DeVries & Ohman, 1994; Martin, Holloway, & Deretic, 1993). In the absence of a specific 
stimulus or in non-mucoidal strains, the anti-sigma factor MucA binds AlgU, causing a 
decrease in the expression of promoters targeted by AlgU. MucB, which is associated to 
the periplasmic domain of MucA, is a negative regulator for the synthesis of alginate. In 
addition, AlgR connects alginate production with antibiotic resistance and QS by 
negatively regulating algT/U expression (Balasubramanian et al., 2011).  
 
1.2.3 Exoproteases 
P. aeruginosa produces exoproteases including elastases, alkaline protease and 
phospholipase C (Plc). The elastolytic zinc metalloprotease elastase B (LasB) is a major 
virulence factor in P. aeruginosa (McIver, Kessler, & Ohman, 2004; Morihara, 1964). 
LasB, also known as pseudolysin, is believed to cause tissue damage in the host by 
hydrolysis of extracellular matrix constituents and by attacking intercellular tight junctions 
(Azghani, 1996; de Bentzmann et al., 2000). It has also been shown to degrade elements 
of the immune system such as TNF-, IFN-, IL-2, IL-8 and surfactant protein A (SP-A) 
(Azghani, 1996) (Horvat, Clabaugh, Duval-Jobe, & Parmely, 1989) (Leidal, Munson, 
Johnson, & Denning, 2003) (Parmely, Gale, Clabaugh, Horvat, & Zhou, 1990) (Theander 
et al., 1988) and antibacterial peptides (Schad et al., 1987). In addition to LasB, the LasA 
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protease (also called staphylolysin) is a 20-kDa endopeptidase secreted by P. aeruginosa 
that has the ability to lyse Staphylococcus aureus (E. Kessler, 1995; E. Kessler, Safrin, 
Olson, & Ohman, 1993) (E. a. D. E. O. Kessler, 1998). LasA is able to hydrolyze the penta-
glycine bridge required for peptidoglycan stabilization in the cell wall of staphylococci,  
but has a low level of elastolytic activity and rather is thought to enhance the elastolytic 
activity of LasB (E. Kessler, Safrin, Abrams, Rosenbloom, & Ohman, 1997).  
1.2.4 Rhamnolipids 
P. aeruginosa produces rhamnolipids, bacterial glycolipidic biosurfactants (Abdel-
Mawgoud, Lepine, & Deziel, 2010) that act as heat-stable extracellular hemolysins 
(Johnson & Boese-Marrazzo, 1980), and lyse polymorphonuclear leukocytes (PMNs) 
(Jensen et al., 2007) and monocyte-derived macrophages (McClure & Schiller, 1992), 
causing necrotic cell death. Rhamnolipids have also been detected in sputum from CF 
patients chronically infected with P. aeruginosa (Read et al., 1992). 
The synthesis of rhamnolipids is carried out by two glycosyl transfer reactions, catalyzed 
by a specific rhamnosyltransferase (Burger, Glaser, & Burton, 1963). The first 
rhamnosyltransferase is encoded by the rhlAB operon, and is in charge of the formation of 
mono-rhamnolipids; the second rhamnosyltransferase, encoded by the rlhC gene, converts 
mono-rhamnolipids into di-rhamnolipids. The expression of these genes is regulated by the 
rhl QS and PQS systems (Deziel, Lepine, Milot, & Villemur, 2003). Antimicrobial activity 
of rhamnolipids have been observed against Gram-negative bacteria such as Serratia, 
Klebsiella and Enterobacter, Gram-positive species including Mycobacterium, 
Staphylococcus, Bacillus and Rhodococccus (Abdel-Mawgoud et al., 2010) and also 
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against fungi but not yeast (Abdel-Mawgoud et al., 2010; Haba et al., 2003). Another 
important function of rhamnolipids is the promotion of swarming motility, defined as a 
rapid and coordinated multicellular movement of bacteria across a semi-solid surface 
(Caiazza, Shanks, & O'Toole, 2005). 
 
1.2.5 Phenazines 
Phenazine compounds are secondary metabolites that are known as redox-active and 
pigmented antibiotics. In P. aeruginosa, these compounds include pyocyanin, phenazine-
1-carboxilic acid (PCA), 1-hydroxyphenazine (1-OH-PHZ) and phenazine-1-carboxiamide 
(PCN), which are regulated by QS.  Pyocyanin is a blue pigment produced and secreted in 
stationary phase and upregulates genes that have been demonstrated to be controlled by QS 
(Dietrich, Teal, Price-Whelan, & Newman, 2008). Because pyocyanin can cross biological 
membranes easily, it serves as a mobile electron carrier for P. aeruginosa. In the soluble 
phase of CF sputum, pyocyanin has been detected at concentrations of up to 27.3 mg/ml 
(130 mM) (Wilson et al., 1988). Hunter et al. revealed that the concentration in sputum 
from CF correlated with the decline in lung function and in the degree of severity of the 
disease fluctuating from 7.7 mM in unobstructed airways to 46.8 mM in severely 
obstructed airways (Paroutis, Touret, & Grinstein, 2004). 
 
 
 
1.2.6 Lectins 
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The ability of pathogenic microorganisms to adhere to host tissues is critical for the onset 
of infection. Adhesion is frequently mediated by surface glycoconjugates which are 
recognized by specific receptors (Karlsson, 2001). In P. aeruginosa, this adhesion is 
mediated by numerous adhesins such as lectins. LecA and LecB, two soluble lectins that 
bind to galactose and fucose respectively, were described in the cytoplasm of this 
bacterium (Glick & Garber, 1983); at the same time, large amounts of these lectins were 
also found in the outer membrane, suggesting that the lectins could play a role in adhesion 
(Glick & Garber, 1983; Tielker et al., 2005). Lectins are regulated by QS and the alternative 
sigma factor RpoS (Winzer et al., 2000). LecA has been shown to: a) have cytotoxicity on 
respiratory epithelial cells through a decrease in their growth rate (Bajolet-Laudinat et al., 
1994); b) induce a permeability defect in the intestinal epithelium, causing an increase in 
absorption of  exotoxin A (Laughlin et al., 2000). LecB was shown to be involved in 
protease IV activity and pilus biogenesis (Sonawane, Jyot, & Ramphal, 2006). 
 
1.2.7 Hfq 
Hfq is a highly conserved RNA chaperone that binds to small non-coding regulatory RNAs 
thereby facilitating their association with mRNAs, the result of which plays a diverse role 
in post-transcriptional regulation of prokaryotic gene expression, virulence, and 
physiology in response to stress (reviewed by (Majdalani, Vanderpool, & Gottesman, 
2005; Valentin-Hansen, Eriksen, & Udesen, 2004)). In P. aeruginosa, Hfq has been 
reported to regulate virulence and stress response (Sonnleitner et al., 2003) (Sonnleitner, 
Schuster, Sorger-Domenigg, Greenberg, & Blasi, 2006). Specifically, Hfq mutants of P. 
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aeruginosa exhibited a 10 to 50-fold decrease in virulence in a murine model of infection 
(Sonnleitner et al., 2003). Moreover, Hfq regulates the production of key virulence factors, 
including alginate, catalase, pyocyanin, elastase, and the las and rhl QS systems (Chugani 
et al., 2001; Gallagher & Manoil, 2001; Passador et al., 1993; Sonnleitner et al., 2003; Suh 
et al., 1999; Usher et al., 2002).  
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A BRIEF BACKGROUND ON Staphylococcus aureus 
Staphylococcus aureus is a Gram positive bacteria belonging to the Staphylococcaceae 
family and the genus Staphylococcus. Staphylococci are facultative anaerobes, catalase 
positive and oxidase negative and can grow at a temperature range of 15 to 45 C and at 
concentrations as high as 15% NaCl. S. aureus are nonmotile and nonsporeforming 
microorganisms. 
S. aureus is a commensal and a pathogen. The anterior nares are the major site of 
colonization in humans. Around 20-30% of individuals are persistent carriers of S. aureus 
and 30% are intermittent carriers (Wertheim et al., 2005). 
This bacterium is one of the main causes of hospital- and community-acquired infections 
(Diekema et al., 2001). Nosocomial S. aureus infections affect the bloodstream, soft 
tissues, skin and lower respiratory tracts. It also causes serious infections such as 
endocarditis and osteomyelitis (Schito, 2006). In addition to the infections just listed, this 
bacterium is often responsible for toxin-mediated diseases such as toxic shock syndrome, 
staphylococcal foodborne disease and scalded skin syndrome. Furthermore, besides its 
ability to cause life-threatening infections, S. aureus has remarkable potential to develop 
antimicrobial resistance, which contributes to its clinical significance. 
S. aureus is equipped with a great variety of virulence factors participating in pathogenesis.  
S. aureus carries surface proteins named “microbial surface components recognizing 
adhesive matrix molecules” (MSCRAMMs) that mediate attachment to host tissues and 
begin colonization leading to an infection. The following are the well-known and studied 
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MSCRAMMs: fibronectin binding proteins A and B, collagen binding protein Can, 
clumping factors A and B and protein A (Plata, Rosato, & Wegrzyn, 2009). 
Previous reports have shown that 60% of the S. aureus strains were able to produce biofilm, 
relevant to the implanted biomedical device-related S. aureus infections on the pathogen’s 
ability to attach to the surface of abiotic as well as abiotic surfaces (Arciola, Baldassarri, 
& Montanaro, 2001). 
Another important virulence factor is the ability of S. aureus to secrete toxins that disrupt 
membranes on host cells such as alpha-hemolysin, beta-hemolysin, gamma-hemolysin, 
leucocidin and PVL (Kaneko & Kamio, 2004) and the superantigen toxin (Kotzin, Leung, 
Kappler, & Marrack, 1993). 
Many of the S. aureus virulence genes are controlled by quorum sensing. This regulation 
is, in large part, due to the accessory gene regulator (agr) two component system (Novick 
& Geisinger, 2008).  
Methicillin-resistant S. aureus (MRSA) was recognized as a major pathogen in the 1980s 
with the emergence of new strains, frequently resistant to multiple different classes of 
antibiotics. MRSA has been isolated with increasing frequency from CF units with 
prevalence rates ranging from 0% to about 23% (Burns et al., 1998).  
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INTRODUCTION 
Cystic fibrosis (CF) is a life-shortening inherited disease that results from a mutation in the 
cystic fibrosis transmembrane conductance regulator (CFTR) gene, which encodes a 
protein involved in the transport of electrolytes across epithelial and other cell membranes 
(Winstanley & Fothergill, 2009). This defect results in the presence of viscous mucus and 
failure in airway mucociliary clearance, leading to life-threatening bacterial infections. The 
most common and important CF airway pathogen is Pseudomonas aeruginosa, which 
affects up to three-fourths of adults (Lipuma, 2010; Lyczak, Cannon, & Pier, 2002) and 
causes chronic pulmonary infections.  
P. aeruginosa is a clinically important Gram-negative bacterium that has developed an 
array of virulence mechanisms and secretes a wide variety of extracellular virulence factors 
such as proteases elastase and LasA (Kamath, Kapatral, & Chakrabarty, 1998; Rumbaugh, 
Griswold, Iglewski, & Hamood, 1999; Tommassen, Filloux, Bally, Murgier, & Lazdunski, 
1992), exotoxin A (Wick, Hamood, & Iglewski, 1990), rhamnolipids (Kownatzki, 
Tummler, & Doring, 1987), pyocyanin, and siderophores (Crosa, 1989).  
The microbial flora of the respiratory tract in patients with CF represents a complex and 
diverse niche in which many microbial species coexist (Harrison, 2007). The majority of 
studies carried out on pathogens associated with CF have focused on three bacterial 
species: P. aeruginosa, Burholderia cepacia and Haemophilus influenzae. In addition, 
patients with CF have a higher frequency of P. aeruginosa-S. aureus co-infections than 
any other patient groups and healthy individuals (Koch, 2002). These two microbial species 
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are the most predominant pathogens found in adult patients with CF 
(CysticFibrosisCanada, 2010, 2011; Kerem, 2006). 
Synthesis of the above mentioned extracellular molecules, most of them controlled by QS, 
are known to reduce the growth of S. aureus, including LasA, AHL, alkyl quinolone N-
oxides (HQNO) and pyocyanin (Goerke & Wolz, 2010; Hoffman et al., 2006; Machan, 
Taylor, Pitt, Cole, & Wilson, 1992; Tashiro et al., 2013).  
Collectively, the above-mentioned factors affect the competition between P. aeruginosa 
and S. aureus and determine not only the outcome of the disease but also pose major 
challenges for clinical management of these patients. 
One of the hallmarks of P. aeruginosa infections impacting CF patients is the establishment 
of biofilms in the highly viscous mucus layer in the lung. The CF lung mucus has been 
reported to contain regions with a steep oxygen gradient that ranges from aerobic to 
anaerobic, due to abnormal oxygen consumption of the epithelial cells and bacterial 
metabolism (Sanderson, Wescombe, Kirov, Champion, & Reid, 2008; Worlitzsch et al., 
2002). Microaerophilic conditions are encountered in the CF lung environment and are the 
preferred growth condition for P. aeruginosa (Costerton et al., 1999; de Beer, Stoodley, 
Roe, & Lewandowski, 1994; Xu, Stewart, Xia, Huang, & McFeters, 1998). It has been 
shown that low oxygen plays an important role in the production of alginate and the 
appearance of mucoid variants of P. aeruginosa (Krieg, Bass, & Mattingly, 1986; Leitao 
& Sa-Correia, 1997; Xu et al., 1998). In a previous paper looking at a mixture of mucoid 
and non-mucoid P. aeruginosa strains, results showed that aerobic culture conditions 
favorably selected  for the growth of mucoid strains; in contrast, sensitivity to oxygen was 
 14 
observed in non-mucoid P. aeruginosa strains, which is a phenotype typically observed in 
CF patients who are chronically infected with this bacterium (Krieg et al., 1986). 
The following findings support the hypothesis that P. aeruginosa is located in low oxygen 
regions of CF lungs: i) evidence of P. aeruginosa growth as microcolonies in the airway 
intraluminal rather than the epithelial surface compartments (Baltimore, Christie, & Smith, 
1989; Jeffery & Brain, 1988; Simel et al., 1984; Worlitzsch et al., 2002); ii) thickened 
mucus and high oxygen consumption by CF epithelium that generates steep oxygen 
gradients within the adherent mucus; iii) bacteria in the thickened mucus can penetrate into 
hypoxic zones; iv) P. aeruginosa can grow in hypoxic/anaerobic CF mucus using available 
electron acceptors; v) increased alginate production by PAO1 strains in response to 
hypoxia, and vi) capacity of P. aeruginosa to proliferate in hypoxic mucus generating 
anaerobic conditions in patients with persistent CF airway infection (Worlitzsch et al., 
2002). 
We hypothesize that low oxygen levels in the CF lung mucus affect the competition 
between P. aeruginosa and S. aureus. Therefore, we studied growth and survival of both 
species in microaerophilic versus aerobic conditions when cultured alone and together, and 
aimed at gaining insight into the virulence factors that contribute to this competition under 
aerobic and microaerophilic conditions. 
Understanding how virulence factors regulated by QS behave under the oxygen conditions 
tested will help in the development of new therapeutic products to control this disease. 
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MATERIALS AND METHODS 
 
Bacterial isolates. P. aeruginosa PAO1 clinical isolate was the prototypical reference 
strain used in the present study. Other clinical isolates of P. aeruginosa and S. aureus were 
obtained from different sites of isolation and their characteristics are listed in Table 1.  
The lasI mutant was derived from the PAO1 strain (source: University of Brussels) 
used in this study. Briefly, an in-frame deletion mutant was constructed by allelic exchange 
(Datsenko & Wanner, 2000). Flanking regions were amplified, cloned into a suicide vector 
and introduced in E. coli S17-1 pir. Recombinant clones were used as donor strain to 
conjugate P. aeruginosa PAO1 strain by tri-parental mating with a helper strain harboring 
plasmid pRK2013. Transconjugants were selected on LB with chloramphenicol and then 
counter-selected in LB without NaCl supplemented with sucrose (the mutant was 
constructed in the laboratory of Prof. Pierre Cornelis at the University of Brussels, and the 
data is not yet published). 
P. aeruginosa strain PAO1 (termed MPAO1, source: University of Washington) 
and the isogenic phzS and lasA mutants (Table 1) were obtained from the University of 
Washington transposon mutant library.  Transposon (derived from Tn5) insertions were 
generated by mating P. aeruginosa PAO1 with E. coli strain SM10pir/pCM639 
(ISphoA/hah insertions) (Jacobs et al., 2003).  
Bacterial strains were grown aerobically (21% O2) and in microaerophilic conditions (2% 
O2) in Lennox L broth base (LB broth, Lennox; Fisher Scientific) at 37 C, with shaking. 
Even though LB is not the ideal medium to use to mimic the CF microenvironment, this 
medium has been extensively used in P. aeruginosa research and it is suitable to compare 
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the results obtained from the study to already published literature. The 2 % concentration 
of oxygen used in this study was used as a reference for an oxygen environment which is 
relevant for the microaerophilic niches in the CF lung. 
 
Competition assays for P. aeruginosa and S. aureus in single and co-culture. 
Competition assays were performed in LB at 37 C in either aerobic (21% O2) or 
microaerophilic conditions (2% O2) with shaking. Co-cultures were inoculated with pure 
cultures of P. aeruginosa and S. aureus grown overnight (15 h, aerated, 37 C, shaking), 
diluted to an OD of 0.01, and combined in a 1:1 ratio. Bacterial cultures were inoculated 
and then grown for 24 h as described above. Samples were serially diluted in sterile 
phosphate-buffered saline (PBS), plated onto LB agar for pure cultures, for co-cultures in 
LB agar plus 50 µg Triclosan (selective media for P. aeruginosa) and Mannitol Salt Phenol 
Red Agar (Sigma Aldrich) (selective media for the isolation of pathogenic Staphylococci) 
to differentiate the two bacterial species. The plates were incubated overnight at 37 C and 
colony forming units (CFU) were enumerated. In initial studies with PAO1, growth of this 
P. aeruginosa strain and also of S. aureus was followed over time and at 24 h no S. aureus 
could be recovered compared to earlier tested time points. Thus, this seems to be a suitable 
time point for comparative studies in competition at different oxygen levels. 
Results are expressed as the average log CFU and each experiment was repeated at least 
twice. Significant differences were considered >2-fold and p<0.05. 
Single culture and co-culture growth curves. Growth curves were performed in LB at 
37 C, in duplicate in aerobic (21% O2) and microaerophilic conditions (2% O2) with 
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shaking. Co-cultures were inoculated by pure cultures of P. aeruginosa and Staphylococcus 
aureus grown overnight, diluted to an OD600 of 0.01, and combined in a 1:1 ratio. At 
different time points (0, 2, 4, 6, 8, 10 and 24 h), samples were serially diluted in sterile 
phosphate-buffered saline (PBS), plated on LB agar for pure cultures or for co-cultures on 
the selective media described above to differentiate the two bacterial species. The agar 
plates were incubated overnight at 37 C and colony forming units (CFU) were 
enumerated. Results are expressed as the average log CFU and each experiment was 
repeated at least twice. 
 
Pyocyanin extraction and quantification. For pyocyanin quantification of single and co-
cultures (made as described above), the cultures were centrifuged after 24 h (8,000 rpm, 5 
min, 25 C), the bacterial pellet was removed and the supernatant filtered-sterilized. Next, 
3 ml of chloroform were added; the solutions were shaken vigorously and the chloroform 
phase collected and transferred to a new glass tube. Further purification of pyocyanin 
consisted of an extraction with 1 ml of 0.2 N HCl followed by spectrophotometric assay at 
550 nm. 
 
Bioassay for the production of 3-oxo-C12-HSL. The detection of extracellular N-3-oxo-
dodecanoyl-L-homoserine lactone (3-oxo-C12-HSL) was performed using the E. coli strain 
harboring reporter plasmid pUCP22NotI-PlasB::gfp(ASV)Plac::lasR (Hentzer et al., 2002) 
which expresses GFP in response to 3-oxo-C12-HSL. The LB plates were overlaid with a 
thin layer of LB containing 0.6% agar (w/v) and 100 µl of an overnight culture of the 
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indicator strain. The central wells in the LB agar (=6 mm) were filled with approximately 
70 µl of culture supernatants. Subsequently, the plates were incubated for 24 h at 37 C. 
The diameter of the green color on the agar is indicative of the concentration of 3-oxo-C12-
HSL in the supernatants. 
 
Elastase secretion. Extracellular elastase was assessed by means of a Congo Red 
colorimetric assay (Aendekerk, Ghysels, Cornelis, & Baysse, 2002; Crabbe et al., 2008). 
The cultures were centrifuged (10,000 g; 4 min) and filtered. One hundred microlitres of 
cell-free culture supernatant were added to glass test tubes containing 10 mg of elastin 
Congo Red (Sigma-Aldrich, USA) in 900 l of 0.1 M Tris HCl (pH 7.2). After 6 h of 
incubation at 37°C, the tubes were centrifuged and the optical density at 495 nm was 
measured with an Ultrospec 3000 spectrophotometer (Pharmacia biotech, New York, 
USA). 
 
Statistical analyses. All experiments were performed at least in duplicate. The statistical 
significance (= 0.05, = 0.01  and = 0.001) was calculated with Microsoft Office Excel 
2013 using a Student’s t-test on the biological replicates of each experimental condition. 
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Table 1. Bacterial strains used in this study 
 
Strain Characteristics Reference 
P. aeruginosa   
PAO1 Prototypic reference strain; 
isolated from a burn wound in 
Melbourne Australia (1954). 
ATCC 15692. 
(Crabbe et al., 2008) 
OZ6 Isolated from a Burn 
Intensive Care Unit (ICU) 
patient, tracheal aspirate. 
Also referred to as MDR6. 
 
(Zaborina et al., 2006) 
ICU3-4-1 Isolated from stool of 
critically ill patient 
(Romanowski et al., 
2012) 
MPAO1 Parent strain (Jacobs et al., 2003) 
PW8155 
(phzS) 
phzS-B10::ISphoA/hah (Jacobs et al., 2003) 
PW4283 
(lasA) 
lasA-B10::ISphoA/hah (Jacobs et al., 2003) 
lasI Deletion mutant Not yet published 
S. aureus   
N315 Isolated in 1982 from the 
pharyngeal smear of a 
Japanese patient with a 
surgical wound; methicillin 
resistant S. aureus (MRSA) 
 
(Kuroda et al., 2001) 
E. coli    
Indicator strain Harbors plasmid 
pUCP22NotI-
PlasB::gfp(ASV)Plac::lasR 
(Hentzer et al., 2002) 
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RESULTS 
Competition between P. aeruginosa and S. aureus under aerobic conditions.  
We assessed the competitive growth of a P. aeruginosa strain collection (PAO1, a lung 
and intestinal clinical isolates, MPAO1, phzS, lasA, and lasI) and S. aureus N315 under 
aerobic (21% O2) conditions. In addition, our collection of P. aeruginosa strains were 
cultured under the same conditions as previously described, as single cultures. Colony 
forming unit (CFU) quantification among the P. aeruginosa strains in single versus co-
culture did not show significant differences (Figure 1A), except for lasI strains which 
showed a considerable reduction (~85 fold) when co-cultured with S. aureus. This result 
may suggest that the las QS system is needed for P. aeruginosa survival in aerobic 
conditions when co-cultured with S. aureus, especially when considered in the context of 
the CF lung, where a range of oxygen gradients are encountered by the polymicrobial 
community. 
The number of CFU of the S. aureus strain N315 as single versus co-culture was 
determined as well (Figure 1B). The growth of S. aureus N315 was significantly and 
strongly inhibited (p<0.01) by the presence of PAO1, the ICU3-4-1 intestinal isolate and 
MPAO1. 
The phzS was also significantly inhibited (p<0.01) (Figure 1B). While not as strongly 
inhibited by the lasA mutant, there was still a significant reduction in viable S. aureus when 
co-cultured with this mutant P. aeruginosa strain (Figure 1B). No significant differences 
(p>0.05) among S. aureus strain N315 co-cultured with P. aeruginosa strain lasI were 
observed (Figure 1B), suggesting that production of 3-oxo-C12-HSL might be an important 
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virulence factor in the competition of P. aeruginosa and S. aureus under aerobic 
conditions. 
Taken together these data indicate that P. aeruginosa strains isolated from different sources 
can outcompete S. aureus N315 in planktonic cultures and that this competition was 
presumably not mediated by pyocyanin but by elastase and the production of 3-oxo-C12-
HSL. 
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Figure 1. Competition assays for P. aeruginosa and S. aureus in aerobic conditions. P. 
aeruginosa (Fig. 1A) strains and S. aureus (N315) (Fig. 1B) were grown for 24 h in LB 
broth in single and co-culture after inoculation at equal ratio from a 15 h overnight culture. 
Cell concentration at 24 h was monitored by colony count after plating on selective media 
for both species. Results are expressed as the mean of values from at least obtained from 
at least two independent experiments. Error bars indicate the standard deviations. 
Statistically significant differences in Student’s t test are indicated by the following 
symbols: ***p<0.001; **p<0.05; *p<0.01. Only significant differences were considered 
for values >2-fold change and p<0.05. Abbreviations: N315 (S. aureus N315), Co-c S (co-
cultured with S. aureus). 
4 5 6 7 8 9 10
N315
PAO1 Co-c S
OZ6 (Lung) Co-c S
ICU3-4-1 (Intestinal)  Co-c S
MPAO1 Co-c S
phzS Co-c S
lasA Co-c S
lasI Co-c S
Average Log CFU/ml
St
ra
in
s
* 
* 
* 
*** 
* 
*** 
A. 
B. 
4 5 6 7 8 9 10
PAO1
OZ6 (Lung)
ICU3-4-1 (Intestinal)
MPAO1
phzS
lasA
lasI
Average Log CFU/ml
St
ra
in
s
Co-culture with N315
Single Culture
**
*
 23 
Competition assays for P. aeruginosa and S. aureus under microaerophilic conditions. 
Next, we explored the effect of competition between the two bacterial species through co-
culture assays under microaerophilic (2% O2) conditions.  The same strains were used in 
this study as for the aerobic competition assays.  
Quantitative analysis of the number of CFU in the P. aeruginosa strain collection showed 
significant differences (p<0.05) when the P. aeruginosa lung isolate and the lasI strains 
were incubated with S. aureus N315 (Figure 2A). In microaerophilic as well as in aerobic 
conditions, a significant difference (p<0.05) in these two P. aeruginosa isolates when co-
cultured with S. aureus; a reduction in the number of Pseudomonas recovered both in the 
OZ6 lung isolate and the lasI mutants of 5.3-fold and 4.4-fold respectively, was observed. 
However, no significant differences in the number of CFU were observed in the following 
combinations: PAO1-S. aureus N315, ICU3-4-1 (intestinal)-N315, MPAO1-N315, phzS-
N315, and lasA-N315 (Figure 2A).  
Figure 2B shows the recovery of S. aureus N315 co-cultured with the P. aeruginosa strains 
collection and S. aureus N315.  
The bacterial co-culture assays among the S. aureus strain N315 with six P. aeruginosa 
strains showed significant differences (Figure 2B). A significant reduction (p<0.001) in the 
number of CFU in S. aureus strain N315 was observed when cultured with P. aeruginosa 
strains PAO1, ICU3-4-1 (intestinal isolate), MPAO1, phzS, lasA, and lasI. However, we 
observed what appeared to be a very slight but significant growth induction (p<0.05) of S. 
aureus strain N315 in the presence of the P. aeruginosa OZ6 (lung) isolate (<2-fold). 
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These results indicate that there is a trend in S. aureus to be more resistant to inhibition by 
P. aeruginosa strains in microaerophilic conditions. 
Statistical analysis performed on competition results showed that there are significant 
differences between aerobic and microaerophilic conditions for all the strains [PAO1, 
ICU3-4-1 intestinal isolate and MPAO1: p<0.001; OZ6 lung isolate, and the phzS, lasA 
and lasI mutants: p<0.01] , indicating that oxygen is playing a role in competition between 
P. aeruginosa and S. aureus.   
Growth curves were also performed in aerobic and microaerophilic conditions and showed 
that all the pseudomonal strains grow well under both oxygen conditions. Growth phase of 
the PAO1, OZ6 lung isolate, ICU3-4-1 intestinal isolate and the MPAO1 strain was not 
affected by oxygen levels at both oxygen concentrations (Figure 3). However, the lasI 
mutant presumably reached the death phase at 21% O2 unlike the other strains, but not at 
2% O2. This finding might explain the significant reduction in the number of the P. 
aeruginosa lasI mutant when co-cultured with S. aureus in the competition assays in 
aerobic conditions. A similar behavior was observed for the phzS and the lasA mutants in 
21% O2, but not to the extent of the lasI mutant. It is important to state that the death phase 
is based on one single data point and additional time points will be generated to confirm 
this finding. 
Modeling of the growth curves is needed to determine the duration of the lag phase, the 
exponential growth rate and the start of the stationary phase as potential differences in 
growth of P. aeruginosa in both oxygen conditions could explain in part, differences in 
competition. 
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Figure 2. Competition assays for P. aeruginosa and S. aureus in microaerophilic 
conditions. P. aeruginosa (Fig. 2A) strains and S. aureus (N315) (Fig. 2B) were grown for 
24 h in flushed and in 2% O2 in LB broth in single and co-culture after inoculation at equal 
ratio from a 15 h overnight culture. Cell concentration at 24 h was monitored by colony 
count after plating on selective media for both species. Results are expressed as the mean 
of values from at least obtained from at least two independent experiments. Error bars 
indicate the standard deviations. Statistically significant differences in Student’s t test are 
indicated by the following symbols: ***p<0.001; **p<0.05; *p<0.01. Only significant 
differences were considered for values >2-fold change and p<0.05.Abbreviations: N315 
(S. aureus N315), Co-c S (co-cultured with S. aureus). 
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Figure 3. Growth curves of Pseudomonas strains in microaerophilic vs. aerobic 
conditions. Cell concentration at 24 h was monitored by colony count plating at different 
time points. Results are given in CFU/ml and are represented as a mean of values obtained 
from at least two independent experiments.  
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3-oxo-C12-HSL activity in P. aeruginosa single and co-cultures under aerobic 
conditions. In order to understand the effect of the las QS system in the competition 
between P. aeruginosa and S. aureus, 3-oxo-C12-HSL activity was assessed under aerobic 
conditions after growth for 24 h. For the single cultures, results showed a weak halo 
indicating the 3-oxo-C12-HSL activity in the P. aeruginosa strain PAO1, the intestinal 
isolate, MPAO1, phzS mutant, and the lasA mutant (Figure 4). No halo was visualized in 
the P. aeruginosa lung isolate indicating that this strain did not produce 3-oxo-C12-HSL. 
S. aureus N315 and the P. aeruginosa lasI mutant, which were used as controls, were 
negative for the production of 3-oxo-C12-HSL as expected. Purified 3-oxo-C12-HSL was 
used as positive control, while LB media was used as negative control. 
The type of bioassay performed for QS detection is not sensitive enough to allow 
visualizing potential differences in QS between both oxygen conditions. 
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Figure 4. Bioassay for the production of 3-oxo-C12-HSL in P. aeruginosa single 
cultures in aerobic conditions. Detection of 3-oxo-C12-HSL using the E. coli strain 
harboring a reporter plasmid expressing GFP in response to 3-oxo-C12-HSL. The halo 
indicates the presence of 3-oxo-C12-HSL in the supernatants. The plus (+) sign indicates a 
positive result for presence of the QS autoinducer. Abbreviations: C(+) [positive control], 
C(-) [negative control]. The white arrows indicate where the halo starts. 
We observed no differences in production of 3-oxo-C12-HSL between single and co 
cultures (Figures 4 and 5). 
C(-): LB 
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These data altogether, confirm previous literature on competition of P. aeruginosa and S. 
aureus in aerobic conditions, in which the inhibition of S. aureus growth was seen in the 
strains positive for the presence of 3-oxo-C12-HSL. 
It should be noted that when we compared the positive control (purified 3-oxo-C12-HSL 
molecule) with the positive strains for the production of this compound, no fluorescence is 
observed in the latter. This could be due to the fact that in the supernatants different 
secreted proteins are present that could inhibit the activity of the QS molecules, or the 
concentration of the QS molecules is too low for visualization of GFP signal with the used 
methods. However, the presence of halos, confirm the production of this QS chemical 
signal and are considered as positive. 
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Figure 5. Bioassay for the production of 3-oxo-C12-HSL in P. aeruginosa and S. aureus 
co-cultures in aerobic conditions. Detection of 3-oxo-C12-HSL using the E. coli strain 
harboring a reporter plasmid expressing GFP in response to 3-oxo-C12-HSL after 24 h. The 
halo indicates the presence of 3-oxo-C12-HSL in the supernatants. The plus (+) sign 
indicates a positive result for the presence of the QS autoinducer. Abbreviations: C(+) 
[positive control], C(-) [negative control], N315: S. aureus N315. The white arrows 
indicate where the halo starts. 
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3-oxo-C12-HSL activity in P. aeruginosa single and co-cultures under microaerophilic 
conditions. The 3-oxo-C12-HSL activity for single cultures of P. aeruginosa strains was 
measured under microaerophilic conditions.  
Results showed a weak halo indicating the 3-oxo-C12-HSL activity in the P. aeruginosa 
strain PAO1, the Intestinal isolate MPAO1, phzS, and lasA (Figure 6); the same outcome 
was observed in single cultures under aerobic conditions indicating that 3-oxo-C12-HSL 
production in both oxygen concentrations under the conditions tested is not affected. 
Previous results have shown that when clinical isolates were measured for the production 
of 3-oxo-C12-HSL, anaerobiosis had an impact on QS activity in a strain dependent manner 
(Fang et al., 2013); those results are consistent with the results presented here, even when 
a small percentage of oxygen is present.  In addition, no halos could be visualized for the 
S. aureus strain N315, the P. aeruginosa lung isolate, and P. aeruginosa lasI; therefore, 
these strains did not show any 3-oxo-C12-HSL activity.  
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Figure 6. Bioassay for the production of 3-oxo-C12-HSL in P. aeruginosa single 
cultures in microaerophilic conditions. Detection of 3-oxo-C12-HSL using the E. coli 
strain harboring a reporter plasmid expressing GFP in response to 3-oxo-C12-HSL after 24 
h. The halo indicates the presence of 3-oxo-C12-HSL in the supernatants. The plus (+) sign 
in some of the strains indicate a positive result for the presence of the QS autoinducer. 
Abbreviations: C(-) [negative control]. The white arrows indicate where the halo starts. 
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Weak halos, indicative of the 3-oxo-C12-HSL activity, were observed in the collected 
supernatants of the co-cultures in the following combinations: PAO1-N315, MPAO1-
N315, phzS-N315 and lasA-N315 (Figure 7). S. aureus growth inhibition is less 
pronounced in 2% oxygen, but it is still present and the results with the lasI mutant under 
the same condition indicate that this inhibition is QS regulated. 
No halos were observed in the co-culture of S. aureus N315 with the P. aeruginosa lung 
or intestinal isolates or the lasI mutant in microaerophilic growth conditions (Figure 7). 
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Figure 7. Bioassay for the production of 3-oxo-C12-HSL in P. aeruginosa with S. 
aureus co-cultures in microaerophilic conditions. Detection of 3-oxo-C12-HSL using the 
E. coli strain harboring a reporter plasmid expressing GFP in response to 3-oxo-C12-HSL 
after 24 h. The halo indicates the presence of 3-oxo-C12-HSL in the supernatants. The plus 
(+) sign in some of the strains indicate a positive result for the presence of the QS 
autoinducer. Abbreviations: C(+) [positive control], C(-) [negative control], N315: S. 
aureus N315. 
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Table 2. Summary of QS results from this study 
 
Strains QS 
 21 % 2 % 
PAO1 + + 
OZ6 (Lung) - - 
ICU3-4-1 (Intestinal) + + 
MPAO1 + + 
phzS + + 
lasA + + 
lasI - - 
PAO1-N315 + + 
OZ6 (Lung)-N315 - - 
ICU3-4-1 (Intestinal)-N315 + - 
MPAO1-N315 + + 
phzS-N315 + + 
lasA-N315 + + 
lasI-N315 - - 
 
Abbreviations: + (positive for the presence of halo), - (negative for the presence of halo), 
QS (Quorum Sensing), N315 (S. aureus N315). 
 
 
 
Pyocyanin production in P. aeruginosa strains in single and co-culture under aerobic 
conditions.  Pyocyanin production by P. aeruginosa strains was determined in single and 
co-culture growth under aerobic conditions (Figure 8). As expected, no pyocyanin 
production in single culture was observed in the S. aureus strain N315. No significant 
differences (p>0.05) were observed in pyocyanin production in the PAO1 strain when 
cultured in single and co-culture conditions. Likewise, there were no significant differences 
(p>0.05) between the other strains tested in this study. As expected, the phzS and lasI 
mutants showed background levels of pyocyanin. 
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High biological variability was observed for the pyocyanin assay and additional 
experiments will determine whether there are significant differences between these strains 
and in different oxygen concentrations. 
 
Figure 8. Pyocyanin production in P. aeruginosa strains in single and co-culture in 
aerobic conditions (21% O2). Pyocyanin absorbance in supernatants of PAO1, lung and 
intestinal isolates, MPAO1 along with P. aeruginosa mutants after 24h. Error bars 
represent standard deviations from the mean (n=2). Statistically significant differences 
between single and co-cultures are indicated by the following symbols: ***p<0.001; 
**p<0.05; *p<0.01. 
 
Pyocyanin production in P. aeruginosa strains single and co-culture under 
Microaerophilic conditions.  Pyocyanin production by P. aeruginosa strains in single and 
co-culture in microaerophilic conditions was determined as described before (Figure 9). 
As expected, no pyocyanin production in single culture was observed in S. aureus strain 
N315. Likewise, no significant differences (p>0.05) in pyocyanin production were found 
for all the strains when cultured in single versus co-culture conditions.  
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The results here showed that the pyocyanin production in aerobic and microaerophilic 
conditions were similar in single and co-culture (p>0.05); however, we did observe a trend 
towards a reduced amount of this compound in microaerophilic conditions. Additional 
experiments will determine whether this trend can be confirmed, since lower pyocyanin 
production in microaerophilic conditions could potentially account for the lower level of 
S. aureus growth inhibition. This reduced effectiveness was shown previously and applies 
for other organisms competing with P. aeruginosa (Winstanley & Fothergill, 2009). 
 
 
 
Figure 9. Pyocyanin production in P. aeruginosa strains in single and co-culture in 
Microaerophilic conditions (2% O2). Pyocyanin absorbance in supernatants of PAO1, 
lung and intestinal isolates, MPAO1 along with P. aeruginosa mutants after 24h (grown in 
LB). Error bars represent standard deviations from the mean (n=2). Statistically significant 
differences in Student’s t test are indicated by the following symbols: ***p<0.001; 
**p<0.05; *p<0.01.  
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Elastase secretion in aerobic and microaerophilic conditions. In order to better 
understand the ability of P. aeruginosa to express elastase under different oxygen 
concentrations, we tested the secretion of this compound during aerobic and low oxygen 
conditions (2% O2). As expected, elastase was detected in the culture supernatants of all 
the strains grown in aerobic conditions and surprisingly, in all of the strains grown at 2% 
O2 and at the same levels.  As expected, the culture supernatant of a mutant in the LasA 
serine protease still exhibits some elastolytic activity due to the synergistic effect with LasB 
to degrade elastin. The elastase levels of the mutant in the LasI synthase were the same as 
those exhibited by S. aureus N315 (Fig. 10). No significant differences (p>0.05) were 
observed in the secretion of elastase between single and co-culture conditions. 
Elastase secretion in P. aeruginosa strains was expected from previous research studies 
performed in aerobic environments. It has been reported that under anaerobic conditions 
elastase activity is significantly repressed for PAO1 (Lee, Yoon, Park, Lee, & Yoon, 2011) 
and other clinical isolates (Fang et al., 2013). However, elastase secretion at 2% O2 had not 
yet been investigated.  
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Figure 10. Elastase Secretion of P. aeruginosa strains in single and co-culture in 
aerobic and microaerophilic conditions. Strains were grown in LB either aerobically 
(21% O2) (panel A) or in microaerophilic conditions (2% O2) (panel B) for 24 h. 
Statistically significant differences in Student’s t test are indicated by the following 
symbols: ***p<0.001; **p<0.05; *p<0.01. 
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DISCUSSION 
The objective of this study was to investigate the influence of oxygen on the competition 
between P. aeruginosa and S. aureus, to enhance our understanding about the interaction 
between these two pathogens in environmental conditions relevant to the cystic fibrosis 
lung mucus.  
We also evaluated the role of targeted virulence factors that are known to play a role in 
competition between these species. In our competition assays we observed striking 
differences between the recovery of S. aureus in the presence of P. aeruginosa isolates in 
aerobic and microaerophilic conditions, showing that oxygen is playing a role in 
competition between these two microorganisms. Specifically, low oxygen levels provided 
a growth/survival advantage for S. aureus in the presence of P. aeruginosa, as compared 
to aerobic conditions. Findings from this study suggested that the lasA and lasI mutants 
competed less effectively with S. aureus regardless of the oxygen level present in the 
culture compared to the isogenic wild type strain. These results are consistent with previous 
findings that elastase and lasI quorum sensing play a role in competitive behavior of P. 
aeruginosa and S. aureus.  
It has been suggested that the CF lung environment is largely anaerobic/microaerophilic 
due to factors such as 1) the presence of CF airway epithelia that consume 2-3 times more 
oxygen than the normal airway epithelia, 2) the high numbers of neutrophils which undergo 
respiratory burst, and 3) growth of a tremendous amount of bacterial and fungal species, 
leading to depletion of the oxygen that is available (Price-Whelan, Dietrich, & Newman, 
2007).  
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One of the most important and clinically relevant polymicrobial associations in the CF lung 
is the one that exists between S. aureus and P. aeruginosa (Peters, Jabra-Rizk, O'May, 
Costerton, & Shirtliff, 2012). In many cases. S. aureus is predominant in childhood 
infections but colonization by P. aeruginosa slowly increases as CF patients grow older. 
However, S. aureus persists and along with P. aeruginosa, these two organisms represent 
the most prevalent species in adult CF patients (CysticFibrosisCanada, 2010, 2011; Kerem, 
2006).  
P. aeruginosa produces a variety of virulence factors with many being controlled by QS 
regulatory systems. Among the arsenal of P. aeruginosa virulence factors, LasA, alkyl 
quinolone N-oxides (HQNO), hydrogen cyanide and pyocyanin have been reported to 
contribute to the reduction of S. aureus growth (Goerke & Wolz, 2010; Hoffman et al., 
2006; Machan et al., 1992) through suppression of aerobic and anaerobic metabolism and 
growth of S. aureus (Biswas, Biswas, Schlag, Bertram, & Gotz, 2009; Hoffman et al., 
2006).   
QS systems in P. aeruginosa have been shown to control the production of factors 
implicated in virulence. This is true for virulence factors known to play a role in 
competition with S. aureus and studied in this project: pyocyanin production and elastase 
secretion (Baldan et al., 2014; Hassan & Fridovich, 1980; E. Kessler et al., 1997).  
The competition in aerobic and microaerophilic conditions performed in this study showed 
that in both conditions, the production of the autoinducer 3-oxo-C12-HSL (made by the Las 
QS system) is important in this competition process when comparing the lasI mutant and 
the QS negative lung isolate to the reference strain PAO1. LasI is an autoinducer synthase 
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that codes for 3-oxo-C12-HSL. Previous reports have shown the implication of this 
autoinducer aiding in the inhibition of S. aureus growth (Haba et al., 2003; Irie, O'Toole 
G, & Yuk, 2005). 
The three P. aeruginosa isolates tested in this study inhibited the growth of S. aureus in 
aerobic conditions (Baldan et al., 2014). These findings are in agreement with previous 
reports. One example is the demonstration of P. aeruginosa inducing lysis of S. aureus to 
use the released iron for its own growth (Mashburn, Jett, Akins, & Whiteley, 2005). The 
same inhibition was observed in the P. aeruginosa phzS strain, responsible for the 
production of pyocyanin synthesis, indicating that pyocyanin presumably does not play a 
major role in the competition under the conditions tested.  Interestingly, neither the lung 
isolate (which is negative for the production of 3-oxo-C12-HSL), the lasA nor the lasI 
mutant strains co-cultured with S. aureus were able to outcompete it effectively, suggesting 
that the lasI QS system plays an important role in the competition of both microbial species. 
In the case of the lung isolate, we can most likely attribute the lower growth inhibition to 
the lack of 3-oxo-C12-HSL production. Indeed, CF lung isolates often lack production of 
3-oxo-C12-HSL (Bjarnsholt et al., 2010; Heurlier et al., 2005; McKeon, Nguyen, Viteri, 
Zlosnik, & Sokol, 2011). However, since this 3-oxo-C12-HSL-negative isolate was still 
able to inhibit S. aureus growth, other antimicrobial effectors presumably played a role in 
the competition as well. By looking at the QS assays in co-culture, most of the P. 
aeruginosa strains tested gave a positive result for the production of the autoinducer, with 
the exception of the lung isolate in both oxygen conditions. This is consistent with the 
competition assays where it was shown that the lung isolate in both oxygen conditions 
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exhibited a reduced ability to reduce the growth of S. aureus, which could suggest that 3-
oxo-C12-HSL could play an important role in this inhibition. In terms of the progression of 
CF, most of the infections in the lung by P. aeruginosa are chronic infections, therefore, 
they are most likely to lose their QS as the disease progresses (Bjarnsholt et al., 2010; 
Heurlier et al., 2005; McKeon et al., 2011). This outcome is linked to loss of regulatory 
systems such as QS that occur during the adaptive process of the bacteria in the CF lung 
(D'Argenio et al., 2007) due to mutations in lasR; approximately 2/3 of the mutations would 
result in a loss of LasR function (Wilder, Allada, & Schuster, 2009). 
Unfortunately, we do not know from which stage of the disease this clinical strain was 
isolated. On the other hand, for the strains positive for 3-oxo-C12-HSL and observing the 
results from the competition assays, there seems to be a correlation between the production 
of this autoinducer and the inhibition of S. aureus.  
Interestingly, growth of S. aureus in the presence of the lung isolate was induced in 2% O2. 
These results altogether suggest that in microaerophilic conditions, S. aureus (which is a 
facultative anaerobe) is more resistant to its growth inhibition than in aerobic conditions.  
This is in accordance to the fact that both species co-exist in the same niche in the CF lung 
and even though P. aeruginosa is always the predominant microorganism in the context of 
CF, there are some studies that suggest that the presence of S. aureus enhances the 
colonization of P. aeruginosa (Loening-Baucke, Mischler, & Myers, 1979).  
If we translate these results into an in vivo setting, it would explain how S. aureus is able 
to survive even in the presence of P. aeruginosa in the context of CF.  
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Pyocyanin has antibiotic activity against other bacteria and fungi, and other organisms such 
as Caenorhabditis elegans (McAlester, O'Gara, & Morrissey, 2008; Price-Whelan, 
Dietrich, & Newman, 2006). This property gives P. aeruginosa an advantage to compete 
with other bacteria occupying the same niche including with S. aureus. The competition in 
aerobic and microaerophilic conditions performed in this study showed that in both 
conditions, the production of pyocyanin is not important in this competition process. Even 
though the experimental data showed considerable variability in the results, the same trends 
can be seen in both oxygen conditions tested. These results are not consistent with previous 
papers, where pyocyanin was shown to have inhibitory effects on the growth of S. aureus 
(Fugere et al., 2014; Qin, Yang, Qu, Molin, & Tolker-Nielsen, 2009; Voggu et al., 2006).  
Likewise, the results presented here contradict previous studies showing an induction of 
pyocyanin when PAO1 was co-cultured with S. aureus under aerobic conditions (Kluge, 
Hoffmann, Benndorf, Rapp, & Reichl, 2012). There have also been reports of anti-
staphylococcal activity by P. aeruginosa present in the sputum of CF patients (Machan et 
al., 1991). High concentrations of pyocyanin in the sputum of CF patients suggest that this 
phenazine plays a vital role in pulmonary tissue damage in chronic lung infections 
(Jayaseelan, Ramaswamy, & Dharmaraj, 2014).   
 However, looking at the competition results (phzS mutant compared to the reference strain 
PAO1) obtained from this study we can see that pyocyanin does not play an important role 
in the competition of P. aeruginosa and S. aureus.  
Elastase (encoded by the lasB gene) is one of the major virulence factors (Blackwood, 
Stone, Iglewski, & Pennington, 1983) secreted into the culture media during aerobic 
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growth by P. aeruginosa. The LasA serine protease has been reported to have staphylolytic 
activity (E. Kessler et al., 1997). 
The competition assays in aerobic conditions showed that the final cell concentration of S. 
aureus is inhibited when co-cultured with the PAO1 strain but not inhibited by the P. 
aeruginosa lasA mutant, suggesting that elastase is an important factor in the competition 
between P. aeruginosa and S. aureus.   
Our results also showed that elastase is secreted into the culture media at the same levels 
during aerobic and microaerophilic growth in the strains tested. This result does not reflect 
previous studies that showed that the secretion of elastase in anaerobic conditions was 
reduced under this condition (Lee et al., 2011); however, we have to take into account the 
fact that in our study a microaerophilic environment (2% O2) was employed, and therefore, 
that low oxygen concentration could account for this observation.  
Despite our efforts to investigate the P. aeruginosa virulence factors that could be affected 
by microaerophilic versus aerobic growth and play a role in differential competition (i.e. 
pyocyanin, elastase A, las QS system), it remains unclear what the underlying cause is of 
the major differences in competitive growth between the oxygen conditions tested. Other 
virulence factors that deserve further study to understand whether they play a role in 
differential competition between 2% O2 and 21% oxygen growth conditions include PQS, 
which is greatly inhibited during anaerobic growth of P. aeruginosa (Schertzer, Brown, & 
Whiteley, 2010; Toyofuku et al., 2008). However, no data has been reported regarding the 
outcome of competition under conditions with reduced oxygen tension.  
 48 
A recently published paper showed that mupirocin, an antibiotic isolated from P. 
fluorescens, has broad antibacterial activity especially against Gram-positive bacteria 
including S. aureus. (Matthijs et al., 2014). 
Cyanide, the other factor that could be involved in explaining these differences, is only 
produced over a narrow spectrum of environmental oxygen tensions (microaerophilic) and 
synthesis is quickly inactivated under atmospheric oxygen and strictly anaerobic conditions 
(Blumer & Haas, 2000). 
The S. aureus clinical strain chosen for this study was not co-isolated with the P. 
aeruginosa strains analyzed - thus further studies are necessary to address the occurrence 
and clinical significance of the P. aeruginosa-S. aureus relationship in co-infected CF 
patients.  
Bacterial population behavior in CF is complex and much more research is required to 
understand the underlying causes of the P. aeruginosa dominated chronic lung infections. 
Studies like those conducted in this work are useful for finding future therapeutic 
alternatives for CF patients that are co-infected by P. aeruginosa and S. aureus. 
Specifically, these studies will aid in the understanding of the CF environmental factors 
that play a role in microbial community dynamics and could provide new therapeutic 
avenues. 
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